Are you an early-stage #startup driving innovation in #SciComm? The #VesaliusInnovationAward is here to recognize and support exceptional ventures like yours! 🚀 Gain media coverage, receive mentoring, and pitch at our live award ceremony. ℹ️ via.karger.com/ #VIA2025

Can #AI help prevent the next #stroke? A #new study published in the Karger journal Cerebrovascular Diseases reveals that AI can detect #AtrialFibrillation (AF) from #brain scans, potentially influence stroke care. AF, an irregular heartbeat, increases stroke risk by five times but often goes undiagnosed until it's too late. AI could make stroke care faster, more accurate, and personalized. More in the latest #PressRelease 🔗 karger.com/pages/newsroom-me…

The Swiss Memory Clinics (SMC) network has released #new national guidelines on the use of anti-amyloid monoclonal antibodies (mAbs) for treating #AlzheimersDisease in Switzerland. These guidelines, published in the Karger journal "Neurodegenerative Diseases", provide exemplary clinical recommendations for #clinicians and #healthcare providers, supporting the advancement of Alzheimer's disease treatment in #Switzerland. More in the latest #PressRelese 🔗 karger.com/pages/newsroom-me…

For 2025, three journals- Developmental Neuroscience, European Addiction Research, and Neurodegenerative Diseases- have met their sustainability thresholds and will provide #OpenAccess without Article Processing Charges (APCs). This model leverages existing library subscriptions to cover publishing costs, making it completely free for readers and authors. We continue to explore sustainable ways to make #HealthScience information globally #accessible. For more details, read the latest #PressRelease 🔗 karger.com/pages/newsroom-me…

1. SARS-CoV-2 Infection and the Neuroendocrine System ✍️ Sasikumar S. and Unniappan S. 📖 #Neuroendocrinology @NeuroKarger karger.com/nen/article-abstr…

Our next interview in the “Meet the Editors-in-Chief” series is with Prof. Dr. @FeiginValery, the editor of the journal Neuroepidemiology. @NeuroKarger Check out the interview ▶️ experience.karger.com/how-we…

#Research doesn’t stop in the lab. Our #new LinkedIn Live series "People & Science" explores inspirational personal stories that are creating a better future for all and offers thought provoking insights into how science impacts people’s lives. Join us for live video conversations with thought leaders in #scientific research, #publishing, #healthcare, and beyond to learn firsthand what sparked their passion, and how their research or projects make a difference in the world. Next live event is tomorrow at 2 p.m. CEST with Dr. Liz O’Riordan and host Francesca Brazzorotto on "Harnessing Social Media for #BreastCancer Awareness". Join us 🔗 ow.ly/9B8r50TMEv5

To all #researchers based in Australia and New Zealand: unlock the secrets to successful #AcademicPublishing! Join us for an insightful #webinar and get invaluable advice on manuscript preparation, successful #submissions, navigating #PeerReviews, and boosting the #impact of your #research. 📅 Don't miss out, register today 🔗 ow.ly/lkcy50TzP59

🚀 Dive into the future of #research with Karger’s #AR technology, powered @ByLudenso ! Transform your #data into immersive 3D experiences and engage your readers 🔗 ow.ly/oNsF50Te2wr #AugmentedReality

Uncover the hidden nuances of #OpenAccess in our next #KargerInConversation event on Thursday, October 24 at 3 p.m. CEST, during #OAWeek. Join three leading experts as they dissect critical terms and concepts like "Transformative Agreement" and "cost neutral" and other key terms, revealing how local biases, historical contexts, and practical challenges shape our understanding. Register now 🔗 register.gotowebinar.com/reg…